Genzyme leads drug stocks higher – MarketWatch

Moneycontrol.comGenzyme leads drug stocks higherMarketWatchEarly Monday, Genzyme (NASDAQ:GENZ) rejected a $69 a share unsolicited offer from French drug maker Sanofi-Aventis (NYSE:SNY) , calling the offer …Sanofi-Aventis (NYSE:SNY) makes Bid for Genzyme (NASDAQ:GENZ)Business and Finance News (blog)Sanofi Takes Bid For Genzyme PublicBenzingaSanofi makes bid for GenzymeMarketWatchistockAnalyst.com (press release) -StreetInsider.com (subscription)all 803 news articles »